Business Standard

Exclusive: Trading strategies for select stocks

Find out stocks that you can bet on in a weak market

Read more on:    Markets | Sensex | Nifty | Stocks | Kunal Bothra | Trading Strategies
Related News

The are trading on a weak note in trades today. Find out that you can bet on in a weak market with , Technical Analyst, LKP Securities.

Smartinvestor : The markets have opened lower are trading on a weak note. What are the levels on the to watch out for? Where are we headed next on the charts?

Kunal Bothra : The markets are bouncing from their 100 DMA. 5950 is a crucial support for Nifty, from where it took a bounce in January as well. However, due to lack of any local triggers, the global markets would hold the key for the next week or so. Any further weakness in those markets and our markets may follow suit.

Smartinvestor : BHEL has been facing the heat of selling pressure post the Q3 result announcement. What is your view on this stock?

Kunal Bothra : 220 level on BHEL was a very crucial support. We had been bearish on the stock since the last couple of months, and believe that the stock can further drift.

Smartinvestor : Which stocks from the heavyweight space are looking attractive for a short term trading horizon?

Smartinvestor : The broader market have been underperforming the benchmark indices. How do you see the mid-caps and small-caps panning out in the near term?

Click her for the full transcript

Read more on:   
|
|
|
|
|

Read More

Sebi clears Diageo's open offer for USL stake

The regulator gives its green signal to Diageo's Rs 5,441-crore open offer for 26% non-promoter United Spirits

Quick Links

 

Market News

Gold, silver rise on seasonal demand, global cues

Gold prices rose by Rs 190, silver by Rs 470

Cardamom up 0.7% on strong demand

Spice for delivery in June gained 0.38%

Palm oil down 0.3% on subdued demand

Oil for delivery in May traded lower by 0.15%

Natco extends gains on US court ruling over generic Copaxone

US Supreme Court ruling paved the way to launch generic version of Teva's Copaxone

Shasun Pharma zooms 40% in three days ahead of board meeting

The board is scheduled to meet today to consider issuing convertible warrants/equity shares on a preferential basis to the promoters.

Back to Top